Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
Shanghai Zhongshan Hospital
Stanford University
Hospital Universitario 12 de Octubre
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Guangxi Medical University
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
South Tyneside and Sunderland NHS Foundation Trust
Yale University
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
Shandong Cancer Hospital and Institute